Oxybutynin Chloride
Product Images NDC 53808-1122

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 53808-1122). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Doh Central Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image For 5mg (Oxybutynin Cl 5mg)

Label Image For 5mg (Oxybutynin Cl 5mg)
This is a medication called Oxybutynin Chloride, which comes in a pack of 30 tablets, each containing 5mg. It is only available with a prescription and is manufactured by a company called KVK. The expiration date of the medication is 07-10-18 and it was packaged by DOH Central Pharmacy in Tallahassee, FL. The rest of the text appears to be a code or batch number.*
FDA Label Image

Structural Formula (Figure 1 Structure)

FDA Label Image

Table 1 (Figure 2 Table1)

Table 1 (Figure 2 Table1)
This text appears to be a table of pharmacokinetic parameters for R-Oybutynin and S-Ouybutynin, likely obtained from a study or experiment. It includes readings for G (ng/ml), Toa (1), AUC (ng=h/mL), and UGy (ngehiml) for both compounds. It is possible that these parameters represent measures of drug concentration, absorption, and metabolism, but without further context or information it is difficult to say with certainty.*
FDA Label Image

Figure 1 (Figure 3 Figure1)

FDA Label Image

Table 2 (Figure 4 Table2)

FDA Label Image

Figure 2 (Figure 5 Figure2)

FDA Label Image

Table 3 (Figure 6 Table3)

Table 3 (Figure 6 Table3)
Oxybutynin Chloride is a medication that can cause adverse effects on various body systems. It can result in urinary tract infections, insomnia, nervousness, dizziness, somnolence, headache, blurred vision, dry mouth, constipation, nausea, dyspepsia, urinary hesitation, and urinary retention.*
FDA Label Image

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.